Stable Gastric Pentadecapeptide BPC 157 Can Improve the Healing Course of Spinal Cord Injury and Lead to Functional Recovery in Rats
This GLP-1 receptor agonist slows gastrointestinal transit and reduces appetite, leading to harder stools and decreased bowel frequency
Structured approaches such as higher-protein, lower-carbohydrate, Mediterranean, or ketogenic regimens have shown potential to improve weight loss, body composition (BC), and metabolic health and may offer synergistic benefits when paired with semaglutide [18,19,20,21]
1 More recently, additional pathophysiologic mechanisms have been identified that are implicated in contributing to impaired glucose homeostasis and the varied metabolic alterations associated with T2DM
Anesthesia and analgesia 2026;142(4):639